Ten years of human papillomavirus vaccination in the United States
LE Markowitz, J Gee, H Chesson, S Stokley - Academic pediatrics, 2018 - Elsevier
Since human papillomavirus (HPV) vaccine was first introduced for females in the United
States in 2006, vaccination policy has evolved as additional HPV vaccines were licensed …
States in 2006, vaccination policy has evolved as additional HPV vaccines were licensed …
Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020–99: a …
Background Cervical screening and human papillomavirus (HPV) vaccination have been
implemented in most high-income countries; however, coverage is low in low-income and …
implemented in most high-income countries; however, coverage is low in low-income and …
Systematic literature review of cross-protective effect of HPV vaccines based on data from randomized clinical trials and real-world evidence
DR Brown, EA Joura, GP Yen, S Kothari… - Vaccine, 2021 - Elsevier
Background The extent of cross-protection provided by currently licensed bivalent and
quadrivalent HPV vaccines versus direct protection against HPV 31-, 33-, 45-, 52-, and 58 …
quadrivalent HPV vaccines versus direct protection against HPV 31-, 33-, 45-, 52-, and 58 …
Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional …
K Kavanagh, KG Pollock, K Cuschieri… - The Lancet infectious …, 2017 - thelancet.com
Summary Background On Sept 1, 2008, Scotland launched routine vaccination for human
papillomavirus (HPV) types 16 and 18, targeted at 12–13-year-old girls, of whom 92· 4 …
papillomavirus (HPV) types 16 and 18, targeted at 12–13-year-old girls, of whom 92· 4 …
Very low prevalence of vaccine human papillomavirus types among 18-to 35-year old Australian women 9 years following implementation of vaccination
DA Machalek, SM Garland… - The Journal of …, 2018 - academic.oup.com
Introduction A quadrivalent human papillomavirus vaccination program targeting females
aged 12–13 years commenced in Australia in 2007, with catch-up vaccination of 14–26 year …
aged 12–13 years commenced in Australia in 2007, with catch-up vaccination of 14–26 year …
Prevalence of human papillomavirus among females after vaccine introduction—National Health and Nutrition Examination Survey, United States, 2003–2014
SE Oliver, ER Unger, R Lewis… - The Journal of …, 2017 - academic.oup.com
Background Human papillomavirus (HPV) vaccine was recommended in 2006 for routine
vaccination of US females aged 11–12 years. Most vaccine used through 2014 was …
vaccination of US females aged 11–12 years. Most vaccine used through 2014 was …
[HTML][HTML] Ecological diversity profiles of non-vaccine-targeted HPVs after gender-based community vaccination efforts
VN Pimenoff, P Gray, K Louvanto, T Eriksson… - Cell Host & Microbe, 2023 - cell.com
The long-term effect of population-level human papillomavirus (HPV) vaccination on the viral
ecology of the untargeted HPVs is poorly understood. We performed an 8-year follow-up of …
ecology of the untargeted HPVs is poorly understood. We performed an 8-year follow-up of …
The impact of the national HPV vaccination program in England using the bivalent HPV vaccine: surveillance of type-specific HPV in young females, 2010–2016
D Mesher, K Panwar, SL Thomas… - The Journal of …, 2018 - academic.oup.com
Background The national human papillomavirus (HPV) immunization program was
introduced in England in September 2008 using the bivalent vaccine. Methods We collected …
introduced in England in September 2008 using the bivalent vaccine. Methods We collected …
HPV type‐specific trends in cervical precancers in the United States, 2008 to 2016
JW Gargano, N McClung, RM Lewis… - … journal of cancer, 2023 - Wiley Online Library
Declines in cervical intraepithelial neoplasia grades 2 to 3 and adenocarcinoma in situ
(CIN2+) observed among young women suggest impact from human papillomavirus (HPV) …
(CIN2+) observed among young women suggest impact from human papillomavirus (HPV) …
Prediction of cervical cancer incidence in England, UK, up to 2040, under four scenarios: a modelling study
A Castanon, R Landy, F Pesola, P Windridge… - The Lancet Public …, 2018 - thelancet.com
Background In the next 25 years, the epidemiology of cervical cancer in England, UK, will
change: human papillomavirus (HPV) screening will be the primary test for cervical cancer …
change: human papillomavirus (HPV) screening will be the primary test for cervical cancer …